Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Canopy Growth (CGC)
NASDAQ:CGC
Earnings Data
Report Date
May 30, 2025TBA Not Confirmed
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.27Last Year’s EPS
-0.73Same Quarter Last Year
Moderate Sell
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 07, 2025
|% Change Since: -42.09%
|Next Earnings Date:May 30, 2025
Earnings Call Sentiment|Neutral
Canopy Growth demonstrated strong performance in medical cannabis and launched successful new products like Claybourne. However, challenges in adult use revenue, overall revenue decline, and increased competition in Australia highlight the difficulties faced. Despite these challenges, the company showed significant improvement in profitability and cash flow, indicating a positive trend towards achieving sustained profitability.Company Guidance
During Canopy Growth's third-quarter fiscal 2025 earnings call, the company provided several key metrics and insights into its performance and future outlook. Consolidated net revenue for the quarter was CAD75 million, marking a 5% decrease year-over-year, or an 8% increase excluding divested businesses. The gross margin stood at 32%, down from 36% the previous year. However, the adjusted EBITDA loss significantly narrowed to CAD3 million, a 61% improvement compared to the same quarter last year, while free cash flow was an outflow of CAD28 million, a 17% improvement year-over-year. The Canadian market saw net revenue of CAD41 million, with notable growth in the medical cannabis segment, up 16%, and an increase in adult-use revenue by 15% quarter-over-quarter. International markets, particularly in Europe, showed promising growth with a 14% year-over-year increase in net revenue, driven by strong performance in Poland and Germany. The Storz & Bickel segment also performed robustly, with a 19% increase in revenue, totaling CAD22 million for the quarter. The company indicated that achieving positive adjusted EBITDA is within reach in the coming quarters and highlighted ongoing efforts to improve profitability and cash flow into fiscal 2026.Medical Cannabis Success
In Canada, medical cannabis business posted record revenue with 16% year-over-year growth. Internationally, Canopy Growth has a strong position in markets like Germany, Poland, and Australia, with European markets experiencing over 70% growth.
Launch of Claybourne Brand
In less than six weeks, the Claybourne brand became the number three infused pre-roll in British Columbia and Ontario, indicating successful market penetration and consumer acceptance.
Storz & Bickel Performance
Storz & Bickel reported a 19% revenue increase to CAD22 million in Q3, driven by robust direct-to-consumer online sales and strong performance in Germany.
Improved EBITDA and Cash Flow
Adjusted EBITDA loss improved by 61% to CAD3 million, and free cash flow outflow improved by 17% to CAD28 million compared to Q3 of fiscal '24.
Successful Cost Reductions
Sales and marketing and G&A expenses declined 24% year-over-year, with significant progress in reducing cash costs related to legacy facilities.
---
CGC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CGC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 07, 2025 | $2.78 | $2.02 | -27.34% |
| Nov 08, 2024 | $4.55 | $4.24 | -6.81% |
| Aug 09, 2024 | $6.92 | $6.37 | -7.95% |
| May 30, 2024 | $8.48 | $8.59 | +1.30% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Canopy Growth (CGC) report earnings?
Canopy Growth (CGC) is schdueled to report earning on May 30, 2025, TBA Not Confirmed.
What is Canopy Growth (CGC) earnings time?
Canopy Growth (CGC) earnings time is at May 30, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CGC EPS forecast?
CGC EPS forecast for the fiscal quarter 2025 (Q4) is -0.27.
---
